Yuriy joined Investor Growth Capital's New York office in 2010 and focuses primarily on biopharmaceutical and medical device investments.
Prior to joining IGC, Yuriy worked at J.P. Morgan as an equity research analyst covering the pharmaceutical sector, specializing in specialty pharmaceuticals and generics companies. Before J.P. Morgan, Yuriy worked at Bank of America Securities as an equity research analyst focusing on large-cap pharmaceuticals companies. Yuriy received his Bachelor of Science degree in both Finance and Economics from New York University’s Stern School of Business.
Yuriy is currently a board observer at Agile Therapeutics and Transcend Medical, and is also actively involved with IGC’s investments in Achillion Pharmaceuticals, Aptalis Pharma, Corcept Therapeutics, and ISTA Pharmaceuticals.